BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1084 related articles for article (PubMed ID: 16687695)

  • 1. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
    Kumar B; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized and persistent erythema nodosum leprosum - a rare variant?
    Prabhu S; Rao R; Sripathi H; Rao L; Singh R
    Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Household costs of leprosy reactions (ENL) in rural India.
    Chandler DJ; Hansen KS; Mahato B; Darlong J; John A; Lockwood DN
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003431. PubMed ID: 25590638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V; Porichha D
    Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of leprosy in children, from a tertiary pediatric hospital in India.
    Mahajan S; Sardana K; Bhushan P; Koranne RV; Mendiratta V
    Lepr Rev; 2006 Jun; 77(2):160-2. PubMed ID: 16895073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic characteristics of leprosy reactions.
    Scollard DM; Smith T; Bhoopat L; Theetranont C; Rangdaeng S; Morens DM
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):559-67. PubMed ID: 7868954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental borderline lepromatous leprosy with intraneural erythema nodosum leprosum in a mangabey monkey (Cercocebus atys).
    Baskin GB; Gormus BJ; Xu K; Martin LN; Wolf RH; Cantrell C; Pezeshkpour GH; Walsh GP; Malaty R; Meyers WM
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):618-23. PubMed ID: 1802944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
    Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.